GTEx SalivaryGland 20-29 vs 50-59 Up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GTEx SalivaryGland 20-29 vs 50-59 Up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GTEx SalivaryGland 20-29 vs 50-59 Up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GTEx SalivaryGland 20-29 vs 50-59 Up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GTEx SalivaryGland 20-29 vs 50-59 Up.

Results found

Linked to

 

Label

Description

 

Gene

double homeobox A pseudogene 8

Gene

p53 upregulated regulator of p53 levels

Gene

MIR31 host gene

Gene

arylacetamide deacetylase pseudogene 1

Gene

long intergenic non-protein coding RNA 2331

Gene

rhabdomyosarcoma 2 associated transcript

Gene

polycystin 1, transient receptor potential channel interacting pseudogene 2

Gene

keratoconus gene 6

Gene

PTPRD antisense RNA 1

Gene

NR4A1 antisense RNA

  • Gene

    double homeobox A pseudogene 8


  • Gene

    p53 upregulated regulator of p53 levels



  • Gene

    arylacetamide deacetylase pseudogene 1


  • Gene

    long intergenic non-protein coding RNA 2331


  • Gene

    rhabdomyosarcoma 2 associated transcript


  • Gene

    polycystin 1, transient receptor potential channel interacting pseudogene 2


  • Gene

    keratoconus gene 6


  • Gene

    PTPRD antisense RNA 1


  • Gene

    NR4A1 antisense RNA

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.